The Last Week’s Deals
Denali Capital Acquisition Corp. (USOTC:DNQAF) at a meeting on Wednesday 9/3/2025, shareholders voted through the company’s acquisition of Semnur Pharmaceuticals with less than 1% of public shares remaining. The company did not give a closing timeline.
Deal Closings & Approvals
Breeze Holdings Acquisition Corp. formerly (USOTC:BRZH) finalized its acquisition of YD Biopharma (NASDAQ:YDES) on Thursday August 28, 2925. After the deal, just 2% of public shares remain. Ordinary shares and warrants are now trading on the NASDAQ as “YDES” and “YDESW.”
Southport Acquisition Corporation (USOTC:PORT) at a meeting on Monday, August 25, 2025, shareholders voted to approve its acquisition of Angel Studios during. Less than 1% of public shares remain outstanding. A closing date has not yet been provided.
IPO News
GSR IV (GSRF) – Raised $230M
Spring Valley III (SVAC) – Raised $200M
S-1 News
FutureCrest Acq (FCRS) – Raised $250M
Leapfrog Acq – Raised $125M
LaFayette Acq (LAFA) – Raised $100M
Miluna Acq (MMTX) – Raised $60M
Liquidations
There no were no liquidations.
Upcoming Meetings and Deadlines
9/9/2025 Alchemy Investments Acquisition Corporation 1 (NASDAQ:ALCY) Liquidation deadline
9/10/2025 Athena Technology Acquisition Corporation II (USOTC:ATEK) Charter extension meeting (liquidation deadline 9/14/2025)
9/14/2025 Patria Latin American Opportunity Acquisition Corporation (NASDAQ:PLAO) Liquidation deadline
9/15/2025 Corner Growth Acquisition Corp (COOL) Authorized capital increase meeting
9/15/2025 Integrated Rail and Resources Acquisition Corporation (USOTC:IRRX) Charter extension meeting (liquidation deadline 9/15/2025)
9/16/2025 WinVest Acquisition Corporation (NASDAQ:WINV) Charter extension meeting (liquidation deadline 9/17/2025)
9/19/2025 AlphaVest Acquisition Corporation (NASDAQ:ATMV) Charter extension meeting (liquidation deadline 9/22/2025)
9/20/2025Flag Ship Acquisition Corporation (NASDAQ:FSHP) Liquidation deadline
This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.